This Project Grant award for $158,500.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The funding supports research at Vanderbilt University focused on "METABOTROPIC GLUTAMATE RECEPTOR 7 AND LEARNING IN NF1". The award period runs from June 1, 2025 to May 31, 2027. Vanderbilt University, a leading private research institution, will conduct this research project to explore innovative approaches to...
The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
This $3,149,863 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a 4-year evaluation of tele-assessment services for autism spectrum disorder (ASD) in underserved communities. The award was made to Vanderbilt University Medical Center (VUMC), a nonprofit academic medical center in Nashville, Tennessee that has extensive experience supporting federal biomedical research and healthcare initiatives through...
The U.S. Defense Health Agency awarded a $962,498 Project Grant to Vanderbilt University Medical Center (VUMC) under the Military Medical Research and Development program (CFDA 12.420) to develop and evaluate a novel tele-assessment tool for autistic adults. The 3-year project, running from September 1, 2023 to August 31, 2026, aims to design and test a remote assessment platform to better support the healthcare needs of this population. As a major academic medical center, VUMC has extensive...
This federal Project Grant award in the amount of $2,399,874.00 was issued by the Defense Health Agency, a component of the Department of the Army, under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives at Vanderbilt University Medical Center (VUMC) focused on "Decoding the Inflammatory Spark and Fire: Unraveling the Molecular Basis of Post-Injury Syndrome and Mineralization Disorders." The 4-year...
This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
The Defense Health Agency awarded a $224,541 Project Grant to the VA Connecticut Research & Education Foundation, Inc. under the Military Medical Research and Development (CFDA 12.420) federal grant program. The three-year grant, which began on April 1, 2025, aims to increase epilepsy self-management access for veterans by embracing a "partnered hub and spoke model." As a non-profit research organization, the VA Connecticut Research & Education Foundation, Inc. specializes in...
This $749,143 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Vanderbilt University Medical Center's "TRAINING THE FUTURE PEDIATRIC WORKFORCE TO IMPLEMENT BEST PRACTICES FOR ASD WITHIN PRIMARY CARE" initiative. The project aims to train future pediatric healthcare providers on best practices for diagnosing and managing autism spectrum disorder (ASD) within primary care settings. The 3-year...
The University of Virginia will receive $238,794 from the Defense Health Agency under a Project Grant award to investigate the mechanisms of seizure-induced death in TSC model mice. The research, to be conducted from June 2023 through May 2025 in Charlottesville, Virginia, aims to further the Military Medical Research and Development program's goal of transforming military and public health through innovative biomedical research solutions. Specifically, the grant will fund the university's...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $525,000 Project Grant to Vanderbilt University Medical Center to investigate novel mechanisms of ovarian cancer initiation in the fallopian tube. The award, effective April 1, 2024 through March 31, 2026, supports biomedical research aimed at improving the health and care of military service members, veterans, and their families. As a sub-award under this grant, Vanderbilt University's...